Clinical Trial Management
Contract Development and Manufacturing
Decentralized Clinical Trials
European Medicines Agency
Hybrid Clinical Trials
In-Vitro Diagnostic Regulation
Outsourcing Clinical Trials
Rare Disease Trials
Research & Development
Research and Development
European Statistical Forum 2022
We are pleased to share that we will be joining the European Statistical Forum this year. This key for statistical experts event will include presentations on such topics as reproducibility,(...)
XV Congresso Nazionale Sihta
We are pleased to share that we will be joining as speakers and sponsors XV Congresso Nazionale Sihta, a key event for Italian Healthcare industry.
Outsourcing in Clinical Trials New England 2022
We are excited to share that we will be attending and exhibiting at Outsourcing in Clinical Trials New England in Boston.
MDIC Annual Patient Forum 2022
We are pleased to share that we will be joining as speakers MDIC Annual Patient Forum 2022 – a key platform for the discussion of how to transform patient engagement throughout the(...)
EADV Congress 2022
We are pleased to share that our team will be attending EADV Congress 2022 in Milan this September. EADV Congress is an outstanding educational and learning experience for dermatologists(...)
We are excited to share that we will be joining BIOMEDevice 2022 as speakers! This event will bring engineers, business leaders, disruptive companies, and innovative thinkers from the(...)
Mobile Tech in Clinical Trials 2022
Join us at Mobile Tech in Clinical Trials, an event focusing on helping R&D operation executives support more patients remotely, including a demo of Health Storyline, our patient-driven(...)
Outsourcing in Clinical Trials Southern California 2022
Join us in San Diego on September 28th and 29th and learn about the unparalleled support and value we can offer at every stage of your corporate and product evolution.
Latest from Alira Health
Regulatory Strategy for Registering Rare Disease Products in the EU
In this webinar we will focus on how to benefit, today and in the future, from the orphan drug program and build a regulatory strategy for successful rare disease product registration(...)
HealthBiz Podcast: Interview with Gabriele Brambilla
Gabriele Brambilla, CEO of Alira Health, has joined the HealthBiz podcast to discuss how Alira Health strives to achieve its mission of humanizing healthcare, the importance of seeing(...)
Business Strategy and Go-to-Market in Medical Robotics
We are pleased to announce that on September 27 we will co-host an online workshop “Business Strategy and Go-to-Market in Medical Robotics” with The Hamlyn Centre for Robotic Surgery.
AseBio and Alira Health Partner to Foster Market Access for Biotech Startups
Alira Health and AseBio, the Spanish Bioindustry Association, are joining forces to support Spanish biotech companies looking to enter new markets.
Alira Health Expands North American Capabilities with the Acquisition of Artisan Healthcare Consulting
The acquisition of Artisan strengthens and extends Alira Health’s Market Access and Management Consulting advisory practices in North America and globally.
Alira Health and Legit.Health Partner to Empower Patients in Dermatology Clinical Research
Alira Health digital health solutions combined with Legit.Health’s AI-driven image assessment tool offer a unique platform for dermatology DCT, RWE and DTx.
Considerations for Analyzing and Interpreting Data from Biometric Monitoring Technologies in Clinical Trials
The rise of technology in clinical research allows us to capture meaningful aspects of health in clinical study participants.
Critical Quality Attributes for Drug Products
In this article, we will explore the importance of Critical Quality Attributes (CQAs) in the drug development lifecycle and why it is vital that your selected CDMO is capable of addressing them.
Best Practices in the CDMO Selection Process
The CDMO series provides sound advice to agile biotech companies in identifying and selecting the right Contract Development and Manufacturing Organization (CDMO) for advancing the(...)